These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26210156)

  • 1. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
    Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.
    Mascalchi M; Maddau C; Sali L; Bertelli E; Salvianti F; Zuccherelli S; Matucci M; Borgheresi A; Raspanti C; Lanzetta M; Falchini M; Mazza E; Vella A; Luconi M; Pinzani P; Pazzagli M
    J Cancer; 2017; 8(12):2223-2230. PubMed ID: 28819424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer.
    Zhang Z; Xiao Y; Zhao J; Chen M; Xu Y; Zhong W; Xing J; Wang M
    Respirology; 2016 Apr; 21(3):519-25. PubMed ID: 26661896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.
    Lindsay CR; Blackhall FH; Carmel A; Fernandez-Gutierrez F; Gazzaniga P; Groen HJM; Hiltermann TJN; Krebs MG; Loges S; López-López R; Muinelo-Romay L; Pantel K; Priest L; Riethdorf S; Rossi E; Terstappen L; Wikman H; Soria JC; Farace F; Renehan A; Dive C; Besse B; Michiels S
    Eur J Cancer; 2019 Aug; 117():60-68. PubMed ID: 31254940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
    Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
    J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
    Carlsson A; Nair VS; Luttgen MS; Keu KV; Horng G; Vasanawala M; Kolatkar A; Jamali M; Iagaru AH; Kuschner W; Loo BW; Shrager JB; Bethel K; Hoh CK; Bazhenova L; Nieva J; Kuhn P; Gambhir SS
    J Thorac Oncol; 2014 Aug; 9(8):1111-9. PubMed ID: 25157764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer.
    Chudasama D; Barr J; Beeson J; Beddow E; McGonigle N; Rice A; Nicholson A; Anikin V
    Anticancer Res; 2017 Jan; 37(1):169-173. PubMed ID: 28011487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
    Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
    Mariscal J; Alonso-Nocelo M; Muinelo-Romay L; Barbazan J; Vieito M; Abalo A; Gomez-Tato A; Maria de Los Angeles CC; Garcia-Caballero T; Rodriguez C; Brozos E; Baron F; Lopez-Lopez R; Abal M
    Sci Rep; 2016 Nov; 6():37820. PubMed ID: 27901069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.